Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 1015.55 -23.90 (-2.30%) | NSE 1016.15 -23.05 (-2.22%) | Trade | Add

BSE Live

Mar 11, 16:01

1015.55 -23.90 (-2.30%)

Volume

AVERAGE VOLUME

5-Day

122,412

10-Day

221,743

30-Day

180,076

88,414

NSE Live

Mar 11, 15:59

1016.15 -23.05 (-2.22%)

Volume

AVERAGE VOLUME

5-Day

2,160,645

10-Day

3,087,677

30-Day

2,249,210

720,555

Financials

Print/Copy to Excel : Go

Cash Flow of Natco Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	2,226.00	1,555.30	770.70	155.90	392.20
Net CashFlow From Operating Activities	1,662.00	1,196.40	784.40	57.70	183.50
Net Cash Used In Investing Activities	-1,443.90	-960.50	-436.60	-92.50	-3.20
Net Cash Used From Financing Activities	-212.40	-237.30	-346.80	35.60	-183.10
Foreign Exchange Gains / Losses	0.00	0.00	0.00	0.00	0.00
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	5.70	-1.40	1.00	0.80	-2.80
Cash And Cash Equivalents Begin of Year	5.50	6.90	5.90	5.10	7.90
Cash And Cash Equivalents End Of Year	11.20	5.50	6.90	5.90	5.10